Five Prime Therapeutics Reports Third Quarter 2015 Results and Provides Business Update
November 4, 2015Highlights from the report include establishment of a license and collaboration agreement with Bristol-Myers Squibb for FPA008 and an expansion of immuno-oncology pipeline with new GITR agonist antibody program
More »
NovaDigm Therapeutics' Chief Executive Officer, Timothy Cooke, Appointed to the National Vaccine Advisory Committee
November 4, 2015Timothy Cooke, Ph.D., serves as a Representative Member from the vaccine industry and represents viewpoints or perspectives of the vaccine manufacturing industry and earlier-stage biotech companies involved in vaccine development.
More »
NeuroPace RNS® System Honored With Prestigious Award At The 22nd Annual Phoenix Conference
November 4, 2015NeuroPace's RNS System received the medical device and diagnostic industry's Most Promising New Product Award at the 2015 Phoenix Medical Device CEO Conference. The award was chosen by leaders in the industry.
More »